Ozone (O~3~) is the most toxic oxidant gas in air pollution mixtures and has been associated with numerous health effects, including airway inflammation and hyperreactivity ([@b38-ehp-118-1721]; [@b47-ehp-118-1721]), exacerbation of asthma ([@b32-ehp-118-1721]; [@b34-ehp-118-1721]), and increased mortality and morbidity ([@b25-ehp-118-1721]). O~3~-induced lung inflammation is characterized by polymorphonuclear leukocyte (PMN) infiltration ([@b33-ehp-118-1721]) and release of a number of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α) ([@b5-ehp-118-1721]; [@b9-ehp-118-1721]), interleukin-6 (IL-6) ([@b26-ehp-118-1721]), and the PMN chemoattractant macrophage inflammatory protein 2 (MIP-2) ([@b15-ehp-118-1721]). O~3~ causes upregulation of inducible nitric oxide synthase (iNOS), which further contributes to lung injury ([@b16-ehp-118-1721]; [@b22-ehp-118-1721]; [@b28-ehp-118-1721]). Lung injury after O~3~ exposure may directly or indirectly affect adaptive immune responses such as T-cell proliferation ([@b24-ehp-118-1721]), response to allergen ([@b12-ehp-118-1721]), and upregulation of costimulatory molecules such as cellular differentiation factor 86 (CD86, B7.2) that contribute to T-cell activation ([@b29-ehp-118-1721]).

Interleuken (IL)-10 is a pleiotropic cytokine that is produced by activated monocytes, macrophages, and helper T-cells, and B-cells. IL-10 reduces TNF-α and IL-6 production ([@b30-ehp-118-1721]), and inhibits MIP-2 ([@b45-ehp-118-1721]). Previously, [@b39-ehp-118-1721] showed that intratracheal instillation of recombinant IL-10 in Sprague-Dawley rats before O~3~ exposure significantly reduced O~3~-induced PMN infiltration and pulmonary hyperpermeability responses \[fibronectin, albumin, bronchoalveolar lavage fluid (BALF) protein\]. However, the relationship between IL-10 and other inflammatory mediators and downstream molecular events has not been investigated. IL-10 inhibits inflammation by suppressing macrophage CD86 expression leading to anergic T-cells in a schistosomiasis model ([@b13-ehp-118-1721]; [@b17-ehp-118-1721]). IL-10 also inhibits iNOS production in macrophages ([@b11-ehp-118-1721]) and blocks nuclear factor-κB (NF-κB) activation ([@b40-ehp-118-1721]). Tyrosine phosphorylation of the intracellular domains of the IL-10 receptor is known to activate the signaling transducer and activator of transcription-3 (STAT3) pathway ([@b14-ehp-118-1721]). [@b46-ehp-118-1721] observed that peptide immunotherapy caused induction of IL-10 and suppressor of cytokine signaling 3 (SOCS3) in a bee venom model, and [@b18-ehp-118-1721] has implicated SOCS3 in inflammatory diseases.

Polymorphisms in the human *IL10* gene have been associated with the development of asthma ([@b6-ehp-118-1721]) and lipopolysaccharide (LPS) sensitivity ([@b42-ehp-118-1721]). The functional role of pulmonary IL-10 has been studied in experimental animals in response to LPS ([@b45-ehp-118-1721]), silica ([@b21-ehp-118-1721]), and infectious organisms ([@b20-ehp-118-1721]) and as a key mediator in allergy ([@b1-ehp-118-1721]) and cystic fibrosis ([@b40-ehp-118-1721]). However, the role of IL-10 in O~3~-induced lung inflammation and its underlying mechanism has not been sufficiently studied.

In this study, we tested the hypothesis that targeted deletion of *Il10* in mice would enhance O~3~-induced pulmonary inflammation via modulation of expression of inflammatory mediators CD86 and MIP-2 and nuclear transcription factors NF-κB and STAT3. We compared O~3~-induced alterations in pulmonary injury phenotypes and putative downstream molecular events between *Il10*-sufficient (*Il10*^+/+^) and *Il10*-deficient (*Il10*^−/−^) mice. We also used global mRNA expression analyses of lung tissue to identify patterns of gene expression that are modulated by IL-10 after exposure to O~3~. Enhanced O~3~-induced inflammation phenotypes in *Il10*^−/−^ mice compared with *Il10*^+/+^ mice were consistent with a protective role for IL-10. Microarray and pathway analyses identified significant differences in inflammatory mediator expression between *Il10*^+/+^ and *Il10*^−/−^ mice in response to O~3~ and suggested novel genetic targets \[e.g., cathepsin E (*Ctse*) and serum amyloid A3 (*Saa3*)\] affiliated with *Il10* expression and response to environmental oxidant exposure.

Materials and Methods
=====================

Animals
-------

We purchased male *Il10*^+/+^ (C57BL/6) and *Il10*^−/−^ (B6.129P2-*Il10^tm1Cgn^*/J) mice (6--8 weeks) from Jackson Laboratories (Bar Harbor, ME). We provided mice with water and pelleted open-formula rodent diet NIH-31 (Zeigler Brothers, Gardners, PA) ad libitum. All experimental procedures were conducted in accordance with approved guidelines from the National Institutes of Health ([@b23-ehp-118-1721]) and the [@b2-ehp-118-1721]. Animals were treated humanely and with regard for alleviation of suffering.

O~3~ exposure
-------------

We placed mice in individual stainless steel wire cages within a Hazelton 1000 chamber (Lab Products, Maywood, NJ) equipped with a charcoal and high-efficiency particulate air--filtered air supply. We exposed mice to 0.3 ppm O~3~ or filtered air for 24, 48, or 72 hr (23.5 hr/day) as described previously ([@b8-ehp-118-1721]).

Necropsy and BALF analyses
--------------------------

We euthanized mice (intraperitoneal sodium pentobarbital, 104 mg/kg) immediately after exposure. We lavaged the right lung with Hanks' balanced salt solution and processed the lung for cell and total protein (a marker of lung permeability) analyses following [@b9-ehp-118-1721]. The left lung was snap-frozen in liquid nitrogen for molecular analyses.

Histological analysis
---------------------

We inflated lavaged right lungs with 10% formalin, removed en bloc, and immersed the lungs in 10% formalin. Details of histological analyses are in the Supplemental Material (doi:10.1289/ehp.1002182). Immunohistological staining was done using a specific antibody against Ki-67 (ab15580; Abcam, Cambridge, MA); we followed the procedures outlined by [@b8-ehp-118-1721].

Real-time quantitative reverse-transcriptase polymerase chain reaction
----------------------------------------------------------------------

We isolated total RNA from left lung homogenates using the RNeasy Midi Kit (Qiagen Inc., Valencia, CA) following the manufacturer's instructions and as described by [@b8-ehp-118-1721]. Details of quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) procedures are outlined in the Supplemental Material (doi:10.1289/ehp.1002182).

Western blot analysis
---------------------

We prepared total lung protein in RIPA buffer containing protease and phosphatase inhibitors. Details of Western blot procedures and analyses are presented in the Supplemental Material (doi:10.1289/ehp.1002182).

Enzyme-linked immunosorbant assay for MIP-2 and NF-κB subunit, p65
------------------------------------------------------------------

We used 50 μL BALF from each mouse for enzyme-linked immunosorbant assay (ELISA). The procedures were performed following manufacturer's instructions (R&D Systems, Minneapolis, MN). Processing and analysis procedures are detailed in the Supplemental Material (doi:10.1289/ehp.1002182).

Nuclear protein isolation and electrophoretic mobility shift assay for NF-κB
----------------------------------------------------------------------------

We prepared nuclear extracts from right lung lobes using a Nuclear Extraction Kit (Active Motif, Carlsbad, CA). Details of the electrophoretic mobility shift assay (EMSA) procedures are in the Supplemental Material (doi:10.1289/ehp.1002182).

Gene array analysis
-------------------

### RNA isolation and Affymetrix GeneChip hybridization

We isolated total RNA from left lung lobes, and the RNA was used after passing quality testing using an Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA, USA). For each treatment group, we performed GeneChip analysis (Affymetrix, Santa Clara, CA) analyses in duplicate (air controls) or triplicate (O~3~ exposed). Further details of RNA processing and hybridization are in the Supplemental Material (doi:10.1289/ehp.1002182).

### Data analysis

We normalized and summarized the resulting files (in CEL format) with the Robust Multichip Average method using RMAExpress (<http://rmaexpress.bmbolstad.com/>). We exported log2 values for analysis using the Spotfire DecisionSite (TIBCO Spotfire, Somerville, MA). Hierarchical clustering identified one outlier, a sample from an *Il10*^−/−^ mouse exposed to O~3~ for 24 hr, which was not included in subsequent analysis. We also applied Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Inc., Redwood City, CA), a structured network knowledge-based approach, to evaluate functions and to elect putative interaction and signaling mechanisms through which IL-10 plays a role in pulmonary pathogenesis in response to O~3~. We further analyzed statistically the CEL files by two-way analysis of variance (ANOVA; *p* \< 0.01) using genotype (*Il10*^+/+^, *Il10*^−/−^) and exposure (air, 24-hr O~3~, 48-hr O~3~, 72-hr O~3~) as the variables in GeneSpring GX 11.0 Expression Analysis software program (Agilent Technologies). We deposited the raw data discussed in this publication into the National Center for Biotechnology Information's Gene Expression Omnibus data repository (<http://www.ncbi.nlm.nih.gov/geo/>, series GSE25095) and the National Institute of Environmental Health Sciences Chemical Effects in Biological Systems database (<http://cebs.niehs.nih.gov/>, accession no. 005-00003-0070-000-5). Details of the processes used to identify genes with altered transcript levels as a function of exposure, strain, and/or time are in the Supplemental Material (doi:10.1289/ehp.1002182). After consolidating probe sets, we loaded the resulting list of 165 genes and annotation into IPA (version 7.4, April 2009) to identify unique gene expression pathways that reflected an interaction between strain and treatment effect.

Statistics
----------

We expressed all data as group means ± SE. We log-transformed PMN data to ensure normal data distribution and equal variance. We assessed differences in effects of O~3~ and IL-10 on response phenotypes by two-factor ANOVA. The factors were exposure (air or O~3~) and genotype (*Il10*^+/+^ or *Il10*^−/−^). Dependent variables were BALF protein concentration, BALF cells, mRNA expression, and protein levels. We used the Student Newman--Keuls post hoc test to compare group means. We performed all statistical analyses using the SigmaStat statistics package (version 3; Systat Software, Inc., Point Richmond, CA). We accepted statistical significance at *p* \< 0.05. Sample sizes are included in the figure captions.

Results
=======

Lung inflammatory responses
---------------------------

O~3~-induced increases in total numbers of BALF cells were significantly greater in *Il10*^−/−^ compared with *Il10*^+/+^ mice \[see Supplemental Material, Table 1 (doi:10.1289/ehp.1002182)\] and largely attributable to differences in total numbers of PMNs. Compared with *Il10*^+/+^ mice, the numbers of PMNs were significantly greater (\~3-fold) in *Il10*^−/−^ mice at each O~3~ exposure time point ([Figure 1A](#f1-ehp-118-1721){ref-type="fig"}). Total BALF protein concentrations also increased significantly in both genotypes after O~3~, but we found no significant differences between the two genotypes (*p* = 0.055; [Figure 1B](#f1-ehp-118-1721){ref-type="fig"}).

Histopathological analysis of lung injury
-----------------------------------------

Consistent with BALF phenotypes, we found greater O~3~-induced inflammation in perivascular, peribronchiolar, and terminal bronchial regions in hemotoxylin and eosin (H&E)-stained lung tissue sections from *Il10*^−/−^ mice compared with *Il10*^+/+^ mice ([Figure 1C](#f1-ehp-118-1721){ref-type="fig"}). Further, the density of Ki67-positive cells at distal perivascular-peribronchiolar areas and centriacinar regions was more prominent in *Il10*^−/−^ than in *Il10*^+/+^ mice exposed to O~3~, indicating enhanced cellular proliferation ([Figure 1D](#f1-ehp-118-1721){ref-type="fig"}).

Inflammatory mediator production
--------------------------------

We did not detect *Il10* mRNA expression in *Il10*^−/−^ mouse lung homogenates after air or O~3~ exposure (data not shown). However, *Il10* mRNA was significantly elevated relative to air-exposed controls after 24-hr O~3~ (4.4-fold; *p* \< 0.05) but was not significantly different between air- and O~3~-exposed *Il10*^+/+^ mice after 48- and 72-hr exposures (data not shown). Relative to respective air controls, O~3~ significantly increased mean BALF concentration of the PMN chemoattractant MIP-2 in both genotypes and was significantly higher in *Il10*^−/−^ compared with *Il10*^+/+^ mice at 24 hr ([Figure 2A](#f2-ehp-118-1721){ref-type="fig"}). However, these genotype-dependent differences were not evident at 48- and 72-hr O~3~. TNF-α and iNOS mRNA expression levels were significantly increased in both strains during O~3~, but we found no significant genotypic differences (data not shown).

SOCS3 expression
----------------

Because SOCS3 has been proposed as a mechanism of IL-10--mediated protection against inflammatory processes in other models of lung disease ([@b18-ehp-118-1721]), we asked whether SOCS3 was differentially expressed in *Il10*^−/−^ and *Il10*^+/+^ mice. Relative to air controls, *Socs3* mRNA expression increased significantly in *Il10*^+/+^ mice after 24-, 48-, and 72-hr O~3~ ([Figure 2B](#f2-ehp-118-1721){ref-type="fig"}); *Socs3* expression in *Il10*^−/−^ mice was increased significantly only after 72-hr O~3~.

CD86 production
---------------

Compared with *Il10*^+/+^ mice, we found significantly higher levels of lung CD86 proteins in *Il10*^−/−^ mice after air and O~3~ ([Figure 2C](#f2-ehp-118-1721){ref-type="fig"}). However, O~3~ did not increase CD86 in either genotype, and we found no interaction between genotype and exposure.

Nuclear NF-κB activity and STAT3 activation
-------------------------------------------

To determine whether the protective effect of IL-10 may be mediated in part by differential NF-κB activity, we evaluated nuclear DNA binding activity of total NF-κB and specific p50, a subunit of NF-κB and p65 κB activity in *Il10*^+/+^ and *Il10*^−/−^ mice. Interestingly, baseline binding activity of total NF-κB and specific p50 κB was slightly greater in *Il10*^−/−^ mice than in *Il10*^+/+^ mice ([Figure 3A](#f3-ehp-118-1721){ref-type="fig"}). O~3~ effects on activation of total NF-κB and specific p50 κB binding activity were more marked in *Il10*^−/−^ mice than in *Il10*^+/+^ mice ([Figure 3A](#f3-ehp-118-1721){ref-type="fig"}). Specific p65 subunit NF-κB activity was significantly increased only in *Il10*^−/−^ mice after O~3~ ([Figure 3A](#f3-ehp-118-1721){ref-type="fig"}). The ratio of phosphorylated STAT3 (p-STAT3) to STAT3 protein in the lung increased significantly after O~3~ compared with air controls in both genotypes, signifying an increase in activated STAT3 protein in response to O~3~ ([Figure 3B](#f3-ehp-118-1721){ref-type="fig"}). However, we found no differences in O~3~-induced increases in the p-STAT3:STAT3 ratio between *Il10*^−/−^ and *Il10*^+/+^ mice.

O~3~-induced gene expression profiles are altered in *Il10*^+/+^ compared with *Il10*^−/−^ mice
-----------------------------------------------------------------------------------------------

We first used unsupervised analyses of gene expression profiles in *Il10*^−/−^ and *Il10*^+/+^ mice to provide additional insight into the means through which IL-10 protects the lung against O~3~-induced inflammation. Using k-means clustering analysis, we identified differential gene expression profile patterns between *Il10*^+/+^ and *Il10*^−/−^ mice that suggested genotype-independent and genotype-specific O~3~ effects \[for gene expression clusters and gene lists, see Supplemental Material (doi:10.1289/ehp.1002182)\]. IPA revealed distinct gene expression pathways for specific O~3~-induced changes that displayed similar kinetics between *Il10*^+/+^ and *Il10*^−/−^ mice \[[Figure 4](#f4-ehp-118-1721){ref-type="fig"}, red shapes; see also Supplemental Material, Table 2, Figure 5A (doi:10.1289/ehp.1002182)\]. For example, *Gale* (galatose-4-epimerase, UDP), *Hat1* (histone acetyl transferase 1), and *Ccr1* \[chemokine (C-C motif) receptor-1\] expression was altered after O~3~ ([Figure 4A](#f4-ehp-118-1721){ref-type="fig"}, red shapes). In addition, we observed O~3~-induced gene expression profile differences in *Il33* in *Il10*^−/−^ and *Il10*^+/+^ mice ([Figure 4B](#f4-ehp-118-1721){ref-type="fig"}, red shapes), *Socs3*, and *Il1* ([Figure 4C](#f4-ehp-118-1721){ref-type="fig"}, red shapes). This is consistent with [Figure 2B](#f2-ehp-118-1721){ref-type="fig"} that shows parallel increases in *Socs3* transcript level in both strains, although statistical testing revealed a significant increase in *Il10*^+/+^ mice earlier than in the *Il10*^−/−^ mice. These genes are associated with stress and inflammatory pathways \[see Supplemental Material, Table 3 (doi:10.1289/ehp.1002182)\]. Moreover, we found O~3~-induced gene expression patterns that were altered temporally in *Il10*^−/−^ compared with *Il10*^+/+^ mice \[[Figure 4](#f4-ehp-118-1721){ref-type="fig"}, green shapes; see also Supplemental Material, Figure 5D, Table 2 (doi:10.1289/ehp.1002182)\].

We also applied supervised analysis using GeneSpring to identify genes that varied statistically significantly between *Il10*^+/+^ and *Il10*^−/−^ mice during 24- to 72-hr O~3~ \[see Supplemental Material, Figure 6, Table 4 (doi:10.1289/ehp.1002182)\]. Genes \> 2-fold higher in *Il10*^−/−^ mice than in *Il10*^+/+^ mice included those encoding CTSE, WDFY1 (WD repeat and FYVE domain containing 1), IL-1β, SAA3, nicotinamide nucleotide transhydrogenase (NNT), and peptidylglycine α-amidating monooxygenase (PAM). Many of these genes were also elucidated by unsupervised analysis \[see Supplemental Material, Table 4 (doi:10.1289/ehp.1002182)\]. We validated a subset of the genes (*n* = 4) listed in the Supplemental Material, Table 4 (doi:10.1289/ehp.1002182), by measuring mRNA expression in lung homogenates from air- and O~3~-exposed *Il10*^−/−^ and *Il10*^+/+^ mice. We found that mRNA expression of *Ctse* (24 hr), *Wdfy1* (24, 48 hr), *Saa3* (48 hr), and *S100a14* (S100 calcium binding protein A14; 24, 48, and 72 hr) was significantly (*p* \< 0.05) greater in *Il10*^−/−^ than in *Il10*^+/+^ lung homogenates \[see Supplemental Material, Figure 7 (doi:10.1289/ehp.1002182)\].

Discussion
==========

We investigated the mechanisms of IL-10--mediated reductions in O~3~-induced airway neutrophilia in mice. Targeted deletion of *Il10* significantly enhanced O~3~-induced pulmonary cellular inflammation, as indicated by significant differences in numbers of infiltrating neutrophils and enhanced cellular proliferation in centriacinar regions compared with *Il10*^+/+^ controls. Nuclear activity of NF-κB and expression of CD86 proteins were also greater in lungs of *Il10*^−/−^ mice. Furthermore, MIP-2 protein was significantly elevated in response to 24-hr O~3~ and was exacerbated in *Il10*^−/−^ compared with *Il10*^+/+^ mice. Results support a role for IL-10 in protection against O~3~-induced inflammation associated with diminished NF-κB activity and MIP-2 production. Nonbiased (visual, unsupervised) and supervised (ANOVA) gene array analysis identified novel cellular targets that may contribute to the protective mechanism of IL-10 in O~3~-induced inflammation.

O~3~-induced increases in BALF neutrophils and lung cell proliferation were significantly enhanced in *Il10*^−/−^ mice relative to *Il10*^+/+^ wild-type controls, but the lung permeability response to O~3~ was not significantly different between the two genotypes. Interestingly, [@b39-ehp-118-1721] found that intratracheal instillation of recombinant IL-10 into Sprague-Dawley rats significantly attenuated by 25% protein permeability responses induced by acute O~3~ exposure (0.8 ppm, 3 hr) compared with controls. An explanation for the disparate observations is not entirely clear, but the role of IL-10 in the hyperpermeability response may depend on the concentration and duration of exposure to O~3~ (0.8 ppm for 3 hr compared with 0.3 ppm for 24, 48, or 72 hr) or may be species specific. Moreover, these results are consistent with previous studies suggesting that inflammatory and permeability responses in this model are regulated through different mechanisms (e.g., [@b8-ehp-118-1721]).

Upregulation of the PMN chemoattractant MIP-2 has been suggested to regulate initial neutrophilic infiltration in response to O~3~. O~3~-induced increases in MIP-2 were potentiated in the absence of *Il10* at 24 hr before the peak PMN influx and therefore may be a mechanism through which IL-10 protects against O~3~-induced inflammation and cell proliferation. Similarly, neutralization of IL-10 prior to LPS administration can attenuate production of MIP-2 and associated neutrophilia ([@b45-ehp-118-1721]). We observed no significantly different O~3~-induced changes in TNF-α and iNOS between *Il10*^−/−^ and *Il10*^+/+^ mice, despite genotype-specific differences in NF-κB after O~3~. These results suggest that O~3~-induced increases in TNF-α and iNOS, which are thought to be NF-κB dependent (e.g., [@b8-ehp-118-1721]), are not modulated by IL-10. These results are inconsistent with those of [@b30-ehp-118-1721] and [@b45-ehp-118-1721], who found that TNF-α production is IL-10 dependent in responses to endotoxin. Collectively, these studies may suggest important differences in pulmonary cellular responses to endotoxin and O~3~ and warrant further investigation.

We also found that lung CD86 protein levels were enhanced in *Il10*^−/−^ compared with *Il10*^+/+^ mice, independent of O~3~ exposure. [@b43-ehp-118-1721] showed that CD86 in alveolar macrophages was significantly enhanced in *Il10*^−/−^ mice at baseline and suggested that low levels of alveolar macrophage costimulatory molecule expression are maintained at least in part by endogenous IL-10 activity. [@b29-ehp-118-1721] found that approximately 8% of alveolar macrophages obtained from rats exposed to 1 ppm O~3~ for 3 days were CD86 positive and suggested that small increases in costimulatory activity may be sufficient to regulate O~3~-induced immune responses. Our data similarly indicate that *Il10* deficiency permits endogenous CD86 expression, which could explain why we did not detect subtle increases in CD86 in *Il10*^−/−^ mice after O~3~ exposure.

To investigate the potential signaling pathway through which IL-10 protects against O~3~-induced inflammation, we evaluated NF-κB activation in *Il10*^+/+^ and *Il10*^−/−^ mice. NF-κB is a nuclear protein that regulates transcription of many gene products that activate major pulmonary inflammatory pathways, including responses to O~3~ ([@b8-ehp-118-1721]). IL-10 inhibits NF-κB ([@b40-ehp-118-1721]; [@b44-ehp-118-1721]). We found that O~3~-induced p50 levels and p65 κB binding activity were significantly greater in *Il10*^−/−^ than in *Il10*^+/+^ mice. The mechanism through which IL-10 inhibits NF-κB may occur indirectly, such as through inhibition of inhibitory kappa kinase, as demonstrated in response to LPS ([@b40-ehp-118-1721]; [@b44-ehp-118-1721]).

STAT3 was associated with IL-10--mediated inhibition of alveolar macrophage activation by LPS ([@b4-ehp-118-1721]). *Stat3* has also been shown to mediate O~3~-induced inflammation ([@b31-ehp-118-1721]) and pulmonary inflammation and hyperresponsiveness associated with asthmatic responses ([@b10-ehp-118-1721]). Interestingly, we found no significant genotype-specific differences in the p-STAT3:STAT3 ratio ([Figure 3B](#f3-ehp-118-1721){ref-type="fig"}). Similarly, gene array analysis did not detect an interaction among O~3~ exposure, *Il10* deficiency, and *Stat3* gene expression at these time points. These results suggest that O~3~-induced STAT3 activation occurs in an IL-10--independent manner.

To further elucidate the potential mechanism through which IL-10 protects the lung against O~3~-induced inflammation, we used k-means clustering and Ingenuity analyses of microarray expression data. We identified three distinct clusters of molecules, representing three pathways and numerous gene targets. Several genes identified in this analysis (e.g., *Il6*, *Il1ra*, *Il1*) contribute to O~3~-induced pulmonary inflammation in mice ([Figure 4](#f4-ehp-118-1721){ref-type="fig"}).

Other identified genes represent novel targets for O~3~-induced inflammation. For example, both gene expression analyses identified *Ctse* as differentially expressed between genotypes after exposure to O~3~. *Ctse* is a an intracellular aspartic protease that is found in immune system cells such as dendritic cells and macrophages and has been implicated in major histocompatibility complex (MHC) class II pathway antigen processing (e.g., [@b48-ehp-118-1721]). Although *Ctse* has not been associated with O~3~-induced inflammation, MHC class II molecules have been implicated recently in the PMN response to O~3~ exposure in the mouse ([@b3-ehp-118-1721]), and it is plausible that CTSE could also be involved in this pathway. SAA and S100A14 have been implicated in inflammatory processes (e.g., [@b19-ehp-118-1721]) or inflammation-related diseases ([@b7-ehp-118-1721]) and thus provide a rationale for a role in O~3~-induced inflammation.

Our gene array analysis identified *Socs3* as being induced in response to O~3~, compared with air controls. RT-PCR analyses confirmed O~3~-induced upregulation of *Socs3* and identified a small but statistically significant difference in expression kinetics between *Il10*^+/+^ and *Il10*^−/−^ mice. Members of the SOCS signaling family, including SOCS3, regulate activation and function of STAT3 ([@b18-ehp-118-1721]). Emerging data on activation and function of STAT3 and SOCS3 in the lung during acute inflammation suggest that these molecules may regulate pulmonary inflammation ([@b18-ehp-118-1721]), and they have specifically been implicated in allergic airway inflammation ([@b37-ehp-118-1721]). Given that SOCS3 is a proximal mediator associated with IL-10 ligand binding, the role of SOCS3 in O~3~-induced inflammation necessitates further investigation to determine its specific contribution to the adaptive/innate immune response.

The array analysis implicated a number of novel genes for response to O~3~ in *Il10*^+/+^ and *Il10*^−/−^ mice, including *Il33* and *Hat1*. IL-33 is a member of the IL-1 superfamily and is expressed on epithelial cells. This cytokine has been identified in joints of arthritis patients ([@b35-ehp-118-1721]) and is implicated in development and regulation of type 2 T-helper cell--dependent immune responses in sites of mucosal immunity, which may suggest a link between innate and adaptive immune responses after O~3~ exposure ([@b41-ehp-118-1721]). HAT1, an acetylation enzyme, controls access to DNA transcription by controlling histone protein activation during chromatin assembly ([@b36-ehp-118-1721]). Although HAT1 expression has been linked to inflammatory mediators such as interferon-γ and TNF-α ([@b27-ehp-118-1721]), the specific role of HAT1 in response to O~3~ remains unclear.

Conclusion
==========

This study supports the hypothesis that IL-10 protects against O~3~-induced lung inflammation and identified several potential mechanisms involved in this response. IL-10 deficiency enhanced O~3~-induced neutrophilic inflammation and injury at the centriacinar region of the lung. Results also suggest that in response to O~3~ the effect of IL-10 may be mediated, in part, via modulation of NF-κB, MIP-2, and CD86. Gene array analysis identified three IL-10--mediated expression pathways with genes known previously to be affected by O~3~ and novel genes that may contribute significantly to the pathogenesis of O~3~-induced pulmonary inflammation. The present investigation identified novel molecular mechanisms of pulmonary O~3~ toxicity, which may provide possible therapeutic targets for attenuating the effects of O~3~ in susceptible individuals.

Supplemental Material is available online (doi:10.1289/ehp.1002182 via <http://dx.doi.org/>).
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![Changes in number of PMNs (*A*) and total protein concentration (*B*) recovered in BALF from *Il10*^+/+^ and *Il10*^−/−^ mice in response to air or 0.3 ppm O~3~ (means ± SE; *n* = 8/group). \**p* \< 0.05, air versus 0.3 ppm O~3~; \*\**p* \< 0.05, *Il10*^+/+^ versus *Il10*^−/−^. (*C*) H&E staining of 5-μm lung sections from *Il10*^+/+^ and *Il10*^−/−^ mice after air or 0.3 ppm O~3~ (72 hr). Arrows illustrate areas of greatest neutrophilic inflammation, particularly around terminal bronchioles (TB) and blood vessels (V). Sections are representative of mice from each treatment group. (*D*) Ki67 immunostaining of 5-μm lung sections from *Il10*^+/+^ and *Il10*^−/−^ mice after air or 0.3 ppm O~3~ (72 hr). Arrows indicate foci of cellular proliferation (arrows indicate the arrowheads shown in the inset). Sections are representative of mice from each treatment group.](ehp-118-1721f1){#f1-ehp-118-1721}

![(*A*) MIP-2 protein levels in BALF recovered from *Il10*^+/+^ and *Il10*^−/−^ mice exposed to air and 0.3 ppm O~3~ (means ± SE; *n* = 4 per group). \**p* \< 0.05, air versus O~3~; \*\**p* \< 0.05, *Il10*^+/+^ versus *Il10*^−/−^. (*B*) *Socs3* mRNA expression in *Il10*^+/+^ and *Il10*^−/−^ mice in response to air or 0.3 ppm O~3~. We determined the ratio of *Socs3* to 18S RNA from whole-lung homogenates from PCR (means ± SE; *n* = 3 per group). \**p* \< 0.05, air versus 0.3 ppm O~3~. (*C*) Lung CD86 protein expression in *Il10*^+/+^ and *Il10*^−/−^ mice exposed to air and 0.3 ppm O~3~ (means ± SE; *n* = 3--5 per group). We detected CD86 expression from whole-lung homogenates by Western blot analysis and reprobed blots with actin for normalization. +*p* \< 0.05.](ehp-118-1721f2){#f2-ehp-118-1721}

![(*A*) EMSA to determine DNA binding activity of total NF-κB (top left) and specific p50 κB (top right) after 0.3 ppm O~3~ in *Il10*^+/+^ and *Il10*^−/−^ mice. Each lane represents nuclear protein pooled from three representative animals of each treatment group and was repeated three times. SB, shifted band; SSB, supershifted band; FP, free probe. Quantified p65 κB determined by ELISA is presented below (means ± SE; *n* = 3 per group). \**p* \< 0.05, air versus 0.3 ppm O~3~; \*\**p* \< 0.05, *Il10*^+/+^ versus *Il10*^−/−^. (*B*) Phosphorylated STAT3 (p-STAT3) in *Il10*^+/+^ and *Il10*^−/−^ mice in response to air or 0.3 ppm O~3~. We determined the ratio of p-STAT3 to total STAT3 from whole-lung homogenates by Western blot analysis (means ± SE; *n* = 3 per group). \**p* \< 0.05, air versus 0.3 ppm O~3~.](ehp-118-1721f3){#f3-ehp-118-1721}

![IPA illustrates the three most highly associated networks (*A*--*C*) of IL-10--dependent genes in response to O~3~. Red symbols, genes whose profiles were derived from Supplemental Material Figure 5A \[see Supplemental Material, Figure 5, Table 2 (doi:10.1289/ehp.1002182)\]; yellow symbols, genes with profiles that followed the pattern illustrated in Supplemental Material Figure 5B (see Supplemental Material, Figure 5, Table 2); green symbols, genes with profiles that differ between *Il10*^+/+^ and *Il10*^−/−^ mice \[see Supplemental Material, Figure 5D, Table 2 (doi:10.1289/ehp.1002182)\]. Gene abbreviations are identified in Supplemental Material, Table 2. GPCR, G-protein--coupled receptor.](ehp-118-1721f4){#f4-ehp-118-1721}

[^1]: The authors declare they have no actual or potential competing financial interests.
